August 12, 2017 / 12:53 AM / 5 days ago

BRIEF-Azurrx Biopharma enters into sublicense agreement with Transchem

Aug 11 (Reuters) - Azurrx Biopharma Inc-

* Azurrx Biopharma Inc - ‍on August 7, 2017, Azurrx Biopharma, Inc entered into a sublicense agreement with Transchem, Inc. - sec filing​

* Azurrx Biopharma- ‍transchem granted co exclusive license to patents,patent apps related to helicobacter pylori 5'-methylthioadenosine nucleosidase inhibitors​ Source text: (bit.ly/2vXjwFJ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below